900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Adverse reaction to fludrocortisone acetate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to fluorouracil	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to flupenthixol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to fluphenazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to flurazepam	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to flurbiprofen	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to folic acid	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to framycetin sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to furosemide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gallamine triethiodide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gamma globulin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ganglion blockers NOS	Limited component (foundation metadata concept)
Adverse reaction to gaseous anesthetic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gaseous anesthetic NOS	Limited component (foundation metadata concept)
Adverse reaction to general anesthetic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gentamicin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glibenclamide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gliclazide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glipizide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to gliquidone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glucagon	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glycerol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glyceryl trinitrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to glymidine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to griseofulvin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to guanethidine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hallucinogen NOS	Limited component (foundation metadata concept)
Adverse reaction to haloperidol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to halothane	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to heavy metal anti-infectives	Ambiguous
Adverse reaction to heavy metal anti-infectives NOS	Limited component (foundation metadata concept)
Adverse reaction to heparin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to homatropine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hormones and synthetic substances NOS	Ambiguous
Adverse reaction to hormones and synthetic substitutes	Ambiguous
Adverse reaction to hydantoin derivatives NOS	Ambiguous
Adverse reaction to hydralazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hydrochlorothiazide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hydrocortisone	Ambiguous
Adverse reaction to hydroflumethiazide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hydroxocobalamin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hydroxyprogesterone hexanoate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hydroxyurea	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hydroxyzine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to hyoscine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to idoxuridine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to imipramine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to indomethacin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to inosine pranobex	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to insulins	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to insulins and antidiabetic agents	Ambiguous
Adverse reaction to insulins and antidiabetic agents	Ambiguous
Adverse reaction to insulins and antidiabetic agents NOS	Classification derived component
Adverse reaction to intravenous anesthetic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to intravenous anesthetic NOS	Limited component (foundation metadata concept)
Adverse reaction to intravenous electrolytes and/or trace elements	Ambiguous
Adverse reaction to iodine or iodide	Ambiguous
Adverse reaction to ipecacuanha	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ipratropium bromide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to iron and iron compounds	Ambiguous
Adverse reaction to iron and iron compounds NOS	Limited component (foundation metadata concept)
Adverse reaction to iron dextran injection	Ambiguous
Adverse reaction to iron sorbitol injection	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to irritant cathartics NOS	Limited component (foundation metadata concept)
Adverse reaction to isocarboxazid	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to isoflurane	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to isoniazid	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to isoprenaline sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to isosorbide dinitrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to isosorbide mononitrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to isoxsuprine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to kanamycin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to kaolin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to keratolytics, keratoplastics and other hair treatment drugs and preparations	Limited component (foundation metadata concept)
Adverse reaction to ketamine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ketazolam	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ketoconazole	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to labetalol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lactulose	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lanatoside C	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lead compound	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to levodopa, L-dopa	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to levorphanol tartrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lignocaine hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lincomycin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to liothyronine sodium	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to liver preparations and other antianemic agents NOS	Classification derived component
Adverse reaction to local anesthetics NOS	Limited component (foundation metadata concept)
Adverse reaction to local anti-infective or anti-inflammatory drug NOS	Limited component (foundation metadata concept)
Adverse reaction to local anti-infectives and anti-inflammatory drugs	Ambiguous
Adverse reaction to lofepramine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lomustine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to loperamide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lorazepam	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lymecycline	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to lypressin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to macrolide NOS	Limited component (foundation metadata concept)
Adverse reaction to macrolide group	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to macrolide group	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to magnesium sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to magnesium trisilicate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 79 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)